Dr. Wolfgang G. Muhlhofer, MD

Dr. Muhlhofer practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Dr. Muhlhofer's NPI, 1699087205, was assigned on July 12, 2010. Dr. Muhlhofer graduated from University of Heidelberg Faculty of Medicine in 2009. Dr. Muhlhofer holds Washington license MD61257976.

Dr. Muhlhofer's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Dr. Muhlhofer's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. Dr. Muhlhofer is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians. Dmand AI also links Dr. Muhlhofer to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muhlhofer practices, 3 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Muhlhofer's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Muhlhofer is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Muhlhofer's licenses on file in 3 states: Washington, Alabama and California.

Dmand AI lists epilepsy and seizures among the conditions Dr. Muhlhofer treats.

CMS data shows 261 Medicare services from Dr. Muhlhofer across 5 procedure codes in 2024, for 141 Medicare patients. Medicare paid $32,034 for them.

CMS counts 141 Medicare patients who saw Dr. Muhlhofer in 2024. The largest group is under 65, with 48 patients. 70% of them have high blood pressure, and 62% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Muhlhofer's median patient age at 41, with 46% women.

In 2024, Dr. Muhlhofer wrote 864 Medicare Part D claims for 174 patients. 87% of them were for generic drugs. CMS names the drug for 755 of them, across 21 drugs with 11 or more claims each, at $243,407 in total drug cost. In 2023, CMS named 505 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Muhlhofer for performance year 2024, reported through an alternative payment model (APM). Dr. Muhlhofer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Muhlhofer as offering telehealth.

Dmand AI links 13 papers to Dr. Muhlhofer, published from 2016 to 2022. 2019 was the busiest year, with 3. The most frequent topics are Electroencephalography, Postoperative Complications and Seizures. Dr. Muhlhofer has published most often in Epilepsia. Dr. Muhlhofer's most frequent co-authors are Kristen O. Riley, Jerzy Szaflarski and Robert C. Knowlton, MD.

CMS Open Payments shows 32 general payments to Dr. Muhlhofer from 7 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 58% of the total. Neuropace, Inc. paid the most, $1,312.

Dr. Muhlhofer graduated from University of Heidelberg Faculty of Medicine in 2009.

Dr. Muhlhofer is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.